| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |